The 6th Global Forum on Tuberculosis Vaccines: this event organized within the framework of the French Presidency of the Council of the European Union will be held in virtual format.
Organized within the framework of the French Presidency of the Council of the European Union and placed under the high patronage of the President of the Republic, and under the patronage of the Minister of Solidarity and Health, the sixth edition of the forum was to take place in France, at the Pierre Baudis Center in Toulouse. However, given the challenges and uncertainties of the evolving health situation, the 6th Global TB Vaccine Forum in Toulouse, France, will be organized as a completely virtual event. To facilitate the participation of stakeholders from around the world, the program will now take place over four days, from February 22 to 25, 2022.
Tuberculosis is a global public health emergency, responsible for 1.5 million deaths worldwide each year. Since 2001, the Stop TB Partnership, the International AIDS Vaccine Initiative (IAVI) and the Tuberculosis Vaccine Initiative (TBVI) have regularly organized the Global TB Vaccine Forum in a different host country. Toulouse, France's bid to host this 6th edition was supported by the Institute of Pharmacology and Structural Biology (IPBS - CNRS/UT3-Paul Sabatier) and the CNRS, with the support of the Toulouse Midi-Pyrénées Federal University as well as many other charitable, industrial and institutional partners.
This forum represents a unique opportunity to inform the international public on the progress of research and its contributions to the fight against tuberculosis, and more generally on infectious diseases and antibiotic resistance, at a time when Europe is witnessing a resurgence of this ancient disease and, more generally, an alarming increase in the threat of infectious diseases.
The program of the 6th Global Forum will cover the entire spectrum of research and development in the field of TB vaccines. It consists of plenary sessions, workshops and poster sessions. Time-shifted broadcasts of key sessions of the program will be provided to allow access to a wider audience in different time zones.
You can already note the presence for the opening and closing sessions of :
- Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (opening session)
- Philippe Sansonetti, Professor Emeritus at the Pasteur Institute and at the Collège de France (opening session)
- Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health (Opening Session)
- Seth Berkley, CEO of GAVI, the Vaccine Alliance (Closing Session)
- Marisol Touraine, Chair of the Unitaid Board of Directors and former French Minister of Health (closing session)